VALEANT PHARMACEUTICALS INTL's ticker is VRX and the CUSIP is 91911K102. A total of 468 filers reported holding VALEANT PHARMACEUTICALS INTL in Q4 2015. The put-call ratio across all filers is 0.90 and the average weighting 1.0%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q4 2016 | $263,022,000 | -50.4% | 18,114,432 | -16.1% | 4.45% | -54.6% |
Q3 2016 | $530,062,000 | +21.9% | 21,591,122 | 0.0% | 9.79% | +69.2% |
Q2 2016 | $434,845,000 | -23.4% | 21,591,122 | 0.0% | 5.79% | -9.8% |
Q1 2016 | $567,847,000 | -66.3% | 21,591,122 | +30.1% | 6.41% | -52.6% |
Q4 2015 | $1,686,488,000 | -51.5% | 16,591,122 | -14.8% | 13.54% | -45.6% |
Q3 2015 | $3,473,760,000 | -19.7% | 19,473,933 | 0.0% | 24.90% | -16.8% |
Q2 2015 | $4,326,134,000 | +11.8% | 19,473,933 | 0.0% | 29.95% | +15.9% |
Q1 2015 | $3,867,913,000 | – | 19,473,933 | – | 25.84% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
Brave Warrior Advisors | 6,050,442 | $763,082,000 | 30.78% |
LeVasseur Capital Partners LLC | 190,404 | $24,014,000 | 29.50% |
FARLEY CAPITAL L.P. | 333,081 | $42,008,000 | 27.09% |
Ruane, Cunniff & Goldfarb | 34,298,384 | $4,325,712,000 | 23.07% |
ValueAct Holdings | 18,923,877 | $2,386,679,000 | 17.64% |
Tesuji Partners | 1,368,040 | $172,537,000 | 17.22% |
Brahman Capital Corp. | 3,902,877 | $492,231,000 | 13.63% |
Arrow Capital Management, LLC | 197,500 | $24,909,000 | 13.60% |
Hound Partners | 2,851,175 | $359,590,000 | 13.45% |
Ratan Capital Management LP | 731,960 | $92,315,000 | 13.09% |